PRKDC and leukemia: The present study revealed that the overexpression of Sp1 activated the DNA-PKcs promoter in U87 cells, which is consistent with another study showed that Sp1 enhances the activity of the DNA-PKcs promoter in daunorubicin-resistant leukemia cell lines (K562/DNR) [13].